CAMK2A and myeloid sarcoma: Further research found that IL-17 induced the occurrence but not the development of mechanical allodynia and thermal hyperalgesia in the MS model, and CaMKIIα was found to participate in IL-17-mediated hyperalgesia by using a CaMKIIα inhibitor.